2 May 2022 , 08:16 AM
Net profit of Bliss GVS Pharma rose 214.58% to Rs 19.63 crore in the quarter ended March 2022 as against Rs 6.24 crore during the previous quarter ended March 2021. Sales rose 26.51% to Rs 167.06 crore in the quarter ended March 2022 as against Rs 132.05 crore during the previous quarter ended March 2021.
For the full year,net profit declined 78.04% to Rs 15.04 crore in the year ended March 2022 as against Rs 68.49 crore during the previous year ended March 2021. Sales rose 29.49% to Rs 747.45 crore in the year ended March 2022 as against Rs 577.21 crore during the previous year ended March 2021.
Particulars | Quarter Ended | Year Ended | ||||
? | Mar. 2022 | Mar. 2021 | % Var. | Mar. 2022 | Mar. 2021 | % Var. |
Sales | 167.06 | 132.05 | 27 | 747.45 | 577.21 | 29 |
OPM % | 12.07 | 12.78 | – | 15.83 | 18.48 | – |
PBDT | 30.72 | 20.85 | 47 | 145.09 | 121.36 | 20 |
PBT | 26.45 | 16.58 | 60 | 127.76 | 104.13 | 23 |
NP | 19.63 | 6.24 | 215 | 15.04 | 68.49 | -78 |
Powered by Capital Market – Live News
Related Tags
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.